Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study
about
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsInfluence of environmental factors in the development of inflammatory bowel diseasesInfluence of environmental factors on the onset and course of inflammatory bowel diseaseEnvironmental triggers for inflammatory bowel diseaseEnvironmental risk factors for inflammatory bowel diseases: a reviewThe therapeutic value of targeting inflammation in gastrointestinal cancersFacing Terminal Ileitis: Going Beyond Crohn's DiseaseAltered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiologyData generation for the Cox proportional hazards model with time-dependent covariates: a method for medical researchers.Coexistence of ulcerative colitis and Sjögren's syndrome in a patient with Takayasu's arteritis and Hashimoto's thyroiditis.Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort studySleep duration affects risk for ulcerative colitis: a prospective cohort study.Etoricoxib and the treatment of ankylosing spondylitis.Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity.Venous and arterial disease in inflammatory bowel disease.Environmental triggers for IBD.Immunology of inflammatory bowel disease and molecular targets for biologics.Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.Identification of Environmental Factors Associated with Inflammatory Bowel Disease in a Southwestern Highland Region of China: A Nested Case-Control Study.High School Diet and Risk of Crohn's Disease and Ulcerative ColitisPain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account.Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn's Disease.Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.Hormone therapy increases risk of ulcerative colitis but not Crohn's disease.Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel DiseaseAssociation between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health StudyInflammatory Bowel Disease Findings From the Nurses' Health Study I and IIIntegrative Therapies and Pediatric Inflammatory Bowel Disease: The Current EvidenceA clinical review of recent findings in the epidemiology of inflammatory bowel disease.Environment and the inflammatory bowel diseases.Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease.A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis.Inflammatory bowel disease: pathogenesis.Zinc intake and risk of Crohn’s disease and ulcerative colitis: a prospective cohort study.Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's diseaseEnvironmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.IBD across the age spectrum: is it the same disease?The cost-effectiveness of infliximab in Crohn's disease.Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: pathophysiology and clinical associations.Epidemiology, risk factors and management of cardiovascular diseases in IBD.
P2860
Q26745700-13B69F68-39AF-44B9-BDB4-CB4654023CB0Q26768257-96730450-5667-41FC-B00A-627169A53DC4Q26774548-685472E9-5F16-413E-9B9D-CAEB4F226FC7Q26851877-087D92C7-9016-4A8F-8317-BA17DA7CD2DBQ26864725-A0802F82-5ABD-43CB-9989-42A62FEA0302Q27024203-70E11F98-4C8B-4B32-A56C-92F71A531CC1Q28077774-D871FF2A-E3B2-4345-BEE1-16E9B2C7D26EQ28534532-6C42655F-BB0C-48D8-B28A-1ECA2E6855DCQ30665555-E011A5F0-2E42-4D20-896F-8D485B23AB0BQ33679195-92DA405F-2847-424D-87F8-F8344C22D739Q34283073-7E0DDF58-F844-4919-AF5B-2F2DD1944783Q34403790-8E3D2FD6-9EF2-45FC-A8FA-E4E7E463E03AQ34466689-AE305957-D299-4826-B36B-2B14137A010FQ34687708-CE6A8392-B84B-41F5-9C09-F1982AA8AA03Q34714365-38140339-499B-436E-A578-8903AD32C219Q35210388-3039DDF9-4992-4821-BD96-F7923DBCF376Q35222593-34F72AEC-815B-44E8-B683-738121459AC6Q35271319-9988F310-D8A6-4A6E-8BAB-D92FE800D562Q35987072-2C36E600-A788-449B-9A69-58C50DB784A2Q36053165-ED8A579A-3C50-439C-B58B-BABC1920B41EQ36058941-214BAE9D-AEDF-4A9E-AE16-006F0E34B091Q36157891-88460604-5D5E-41C7-82D7-4FEB7A93DCF0Q36174814-2F6054D4-F7EC-49E4-A91A-D0D53BB6B24FQ36345322-CF5165FF-5EF3-4626-ABDB-2406B1551E3AQ36437092-BF4CA2F8-3842-4B36-AB0B-13C3AC4CD69CQ36655096-5DA2C847-FCA2-415A-9AA3-41E5E775B40CQ36848429-243EFE54-6954-4E14-AB8E-4EB8CC3097FDQ37055823-757B61C3-BB45-44BA-A909-C276C7151A88Q37057066-750BBB53-28E9-464A-8740-1B155487F77DQ37066404-3F956FA6-CB68-4F1E-8934-F2DEDBB057A0Q37098427-039475D5-A337-41B7-9933-76DDF42F04C9Q37248661-917C28A5-F0FD-4FA9-843E-A4CEA06C358BQ37454586-0E46F576-294D-4640-989E-7FBBF90C2144Q37503004-8CA365E7-E75F-4FF1-811D-BE5F5D165794Q37558674-5C808494-8426-48BC-9992-EF010A3199F7Q37723798-CA700A73-4278-41C1-8F3B-61A688083A41Q38171927-2FA5753B-50AE-4B5F-A2CF-2A57A65EAA5EQ38241338-B2DFBE0A-B870-42B7-B77A-2B4ECA095085Q38250401-042D3D79-570B-49F2-A490-CA139F9FF2B0Q38275040-481ACF44-9BE5-4C83-A6EF-7F7C286E8745
P2860
Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Aspirin, nonsteroidal anti-inf ...... rative colitis: a cohort study
@ast
Aspirin, nonsteroidal anti-inf ...... rative colitis: a cohort study
@en
type
label
Aspirin, nonsteroidal anti-inf ...... rative colitis: a cohort study
@ast
Aspirin, nonsteroidal anti-inf ...... rative colitis: a cohort study
@en
prefLabel
Aspirin, nonsteroidal anti-inf ...... rative colitis: a cohort study
@ast
Aspirin, nonsteroidal anti-inf ...... rative colitis: a cohort study
@en
P2093
P2860
P1476
Aspirin, nonsteroidal anti-inf ...... rative colitis: a cohort study
@en
P2093
Andrew T Chan
Ashwin N Ananthakrishnan
Edward S Huang
Hamed Khalili
James M Richter
Leslie M Higuchi
P2860
P304
P356
10.7326/0003-4819-156-5-201203060-00007
P407
P577
2012-03-01T00:00:00Z